Citadel Advisors
BLUE

Citadel Advisors’s bluebird bio BLUE Stock Holding History

Citadel Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-146,225
Closed -$714K – 12621
2025
Q1 		$714K Sell
146,225
-950
-0.6% -$5.71K ﹤0.01% 7704
2024
Q4 		$1.23M Buy
147,175
+138,955
+1,690% +$1.21M ﹤0.01% 6602
2024
Q3 		$85.4K Sell
8,220
-1,570
-16% -$26.1K ﹤0.01% 11326
2024
Q2 		$193K Buy
9,790
+3,670
+60% +$73.5K ﹤0.01% 9994
2024
Q1 		$157K Sell
6,120
-14,055
-70% -$360K ﹤0.01% 10703
2023
Q4 		$557K Buy
20,175
+13,020
+182% +$794K ﹤0.01% 7865
2023
Q3 		$435K Buy
7,155
+990
+16% +$69.5K ﹤0.01% 8374
2023
Q2 		$406K Sell
6,165
-2,135
-26% -$156K ﹤0.01% 8386
2023
Q1 		$528K Sell
8,300
-5,295
-39% -$605K ﹤0.01% 8191
2022
Q4 		$1.88M Sell
13,595
-480
-3% -$67.6K ﹤0.01% 5604
2022
Q3 		$1.78M Buy
14,075
+7,955
+130% +$900K ﹤0.01% 5812
2022
Q2 		$507K Buy
6,120
+735
+14% +$57K ﹤0.01% 8607
2022
Q1 		$522K Sell
5,385
-4,805
-47% -$634K ﹤0.01% 9285
2021
Q4 		$2.04M Buy
10,190
+4,253
+72% +$1M ﹤0.01% 6189
2021
Q3 		$1.47M Sell
5,937
-316
-5% -$90.3K ﹤0.01% 7125
2021
Q2 		$2.59M Sell
6,253
-3,798
-38% -$1.5M ﹤0.01% 5943
2021
Q1 		$3.93M Buy
10,051
+3,427
+52% +$1.69M ﹤0.01% 4804
2020
Q4 		$3.71M Buy
6,624
+2,548
+63% +$1.61M ﹤0.01% 4203
2020
Q3 		$2.85M Sell
4,076
-2,586
-39% -$2.02M ﹤0.01% 4069
2020
Q2 		$5.27M Buy
6,662
+1,057
+19% +$797K ﹤0.01% 3013
2020
Q1 		$3.34M Sell
5,605
-1,706
-23% -$1.66M ﹤0.01% 3293
2019
Q4 		$8.31M Sell
7,311
-31
-0.4% -$33.7K ﹤0.01% 2428
2019
Q3 		$8.73M Buy
7,342
+1,259
+21% +$1.92M ﹤0.01% 2384
2019
Q2 		$10M Sell
6,083
-541
-8% -$936K ﹤0.01% 2176
2019
Q1 		$13.5M Sell
6,624
-5,728
-46% -$10.1M 0.01% 1717
2018
Q4 		$15.9M Buy
12,352
+386
+3% +$592K 0.01% 1420
2018
Q3 		$22.6M Sell
11,966
-2,779
-19% -$5.74M 0.01% 1296
2018
Q2 		$30M Buy
14,745
+6,021
+69% +$13.7M 0.01% 990
2018
Q1 		$19.3M Buy
8,724
+1,776
+26% +$4.52M 0.01% 1147
2017
Q4 		$16M Buy
6,948
+556
+9% +$1.13M 0.01% 1317
2017
Q3 		$11.4M Buy
6,392
+3,057
+92% +$4.27M 0.01% 1493
2017
Q2 		$4.54M Buy
3,335
+803
+32% +$969K ﹤0.01% 2226
2017
Q1 		$2.98M Sell
2,532
-687
-21% -$701K ﹤0.01% 2590
2016
Q4 		$2.57M Sell
3,219
-1,405
-30% -$1.12M ﹤0.01% 2674
2016
Q3 		$4.06M Buy
4,624
+2,184
+90% +$1.58M ﹤0.01% 2187
2016
Q2 		$1.37M Buy
2,440
+556
+30% +$315K ﹤0.01% 3169
2016
Q1 		$1.04M Sell
1,884
-1,073
-36% -$659K ﹤0.01% 3443
2015
Q4 		$2.46M Sell
2,957
-880
-23% -$879K ﹤0.01% 2533
2015
Q3 		$4.25M Buy
3,837
+1,637
+74% +$2.98M ﹤0.01% 2107
2015
Q2 		$4.8M Sell
2,200
-680
-24% -$1.39M ﹤0.01% 2108
2015
Q1 		$4.5M Buy
2,880
+1,730
+150% +$2.28M ﹤0.01% 2133
2014
Q4 		$1.37M Sell
1,150
-162
-12% -$108K ﹤0.01% 3364
2014
Q3 		$610K Buy
1,312
+1,158
+752% +$534K ﹤0.01% 4368
2014
Q2 		$77K Buy
+154
New +$49.4K ﹤0.01% 6428

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's BLUE Position: Q3 2024 in Review

Citadel Advisors sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 10,390 shares — an estimated $173K sold.

Citadel Advisors first reported a position in BLUE in Q2 2013 and held it in 39 quarters. The position peaked at $69.6M in Q4 2019. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Citadel Advisors reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 10,390 bluebird bio shares in Q3 2024, an estimated $173K.
  • Citadel Advisors first reported a position in bluebird bio in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's bluebird bio position peaked at $69.6M in Q4 2019.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.